Data analysis Puts PACE Chronic Fatigue Syndrome Trial on Slippery Slope to Retraction
The issue at stake was a big one. It asked whether changes to the original protocol of the PACE trial ended up stacking the deck. It was easy to see how they might have; some of the recovery criteria were so weird as to seem ridiculous. The changes in the studies...
The Lancet Flubs PACE Letter: Exposes Journal to Ridicule
“…science has taken a turn towards darkness” Richard Horton, editor of the Lancet The latest PACE controversy started with a simple invitation from Richard Horton, the editor of The Lancet – to 42 signers of a letter requesting that an...
The NIH’s Big Change: Is it Coming For Chronic Fatigue Syndrome (ME/CFS)?
VIcky Whittemore and Dr. Koroshetz head the Trans NIH Working group for ME/CFS which is leading the charge to reinvigorate chronic fatigue syndrome (ME/CFS) research at the NIH. As the largest research funder in the world NIH funded research plays a major in the...Help us Ask NIH to fund an Ampligen Trial Today!
NIH is asking the ME/CFS community what future research should be done. We are submitting a request to have NIH fund clinical trials for ME/CFS starting with Ampligen, as the only medication close to approval in the FDA pipeline. If you want to add your name to this...
Ron Davis on Possibly Explaining (Almost) Everything in ME/CFS: The #MissingMillions Talk
Ron Davis’s electrifying talk at the #MissingMillion’s event in San Francisco indicates he believes the Open Medicine Foundation’s Severely Ill study is already opening beachheads in this disease that could explain much. Check out that and more news...StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
